S. Putney

发表

Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs

J. Berzofsky, R. Germain, Hidemi Takahashi, 1990, Nature.

Intravenous administration of a transferrin receptor antibody-nerve growth factor conjugate prevents the degeneration of cholinergic striatal neurons in a model of Huntington disease.

J. Kordower, R. Bartus, V. Charles, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization

M. Hammarskjöld, P. Rennert, R. Grimaila, 1992, Journal of virology.

Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzees

S. Matsushita, W. Schleif, E. Emini, 1990, Journal of virology.

Structural and functional features of the HIV envelope glycoprotein and considerations for vaccine development.

D. Bolognesi, J. Rusche, S. Putney, 1990, Biotechnology.

Toxicology and Biocompatibility Evaluation of Microsphere and Liposome Sustained-Release Drug Delivery Systems

S. Putney, M. Riley, 2000 .

Encapsulation of proteins for improved delivery.

S. Putney, 1998, Current opinion in chemical biology.

Type-restricted neutralization of molecular clones of human immunodeficiency virus.

R. Redfield, D. Burke, R. Gallo, 1988, Science.

Isolation of a functional human gene for brain creatine kinase.

R. Kingston, P. Schimmel, R. Kaddurah-Daouk, 1988, The Journal of biological chemistry.

Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide.

C. DeLisi, H. Margalit, J. Cornette, 1987, Proceedings of the National Academy of Sciences of the United States of America.

T cell multideterminant regions in the human immunodeficiency virus envelope: toward overcoming the problem of major histocompatibility complex restriction.

C. DeLisi, H. Margalit, J. Cornette, 1989, International immunology.

Bifunctional fusion between nerve growth factor and a transferrin receptor antibody

M. J. Coloma, S. Morrison, X. Cao, 1997, Journal of neuroscience research.

The rabbit muscle phosphofructokinase gene. Implications for protein structure, function, and tissue specificity.

M. Kao, C. Lee, S. Putney, 1987, The Journal of biological chemistry.

Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein

J. Berzofsky, B. Moss, R. Germain, 1989, The Journal of experimental medicine.

Characterization, receptor mapping and blood-brain barrier transcytosis of antibodies to the human transferrin receptor.

R. Obar, T. Olson, P. Friden, 1996, The Journal of pharmacology and experimental therapeutics.

Development and monitoring of purification process for nerve growth factor fusion antibody

X. Cao, T. Londo, R. Hamilton, 1995 .

Multideterminant regions of the HIV-1 envelope with sites seen by murine and human helper T cells: circumventing the MHC restriction problem

C. DeLisi, J. Cornette, K. Cease, 1990 .

B and T cell reactivities after immunization of macaques with HIV subcomponents.

R. Kurth, F. Chiodi, E. Fenyö, 1988, AIDS Research and Human Retroviruses.

A unidirectional deletion technique for the generation of clones for sequencing

E. Ozkaynak, S. Putney, 1987 .

Prospects for development of a vaccine against HIV-related disorders

H. Lyerly, D. Bolognesi, T. Matthews, 1987 .

Prospects for development of a vaccine against HTLV-III-related disorders.

H. Lyerly, R. Gallo, D. Bolognesi, 1987, AIDS research and human retroviruses.

Microspheres for Protein and Peptide Delivery: Applications and Opportunities

S. Putney, P. Burke, 2000 .

Human immunodeficiency virus type 1 entry into T cells: more-rapid escape from an anti-V3 loop than from an antireceptor antibody

H. Robinson, S. Lu, S. Putney, 1992, Journal of virology.

A Large-Scale Process to Produce Microencapsulated Proteins

J. Cleland, M. Tracy, S. Putney, 1998, Pharmaceutical Research.

Peptide from a prokaryotic adhesin blocks leukocyte migration in vitro and in vivo.

R. Starzyk, E. Tuomanen, B. Spellerberg, 1995, The Journal of infectious diseases.

The Stabilization and Encapsulation of Human Growth Hormone into Biodegradable Microspheres

J. Cleland, Jeffrey L. Cleland, OluFunmi L. Johnson, 1997, Pharmaceutical Research.

HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope.

A J Langlois, J. Ghrayeb, M. Robert-Guroff, 1986, Science.

Improving protein therapeutics with sustained-release formulations

Scott D. Putney, S. Putney, Paul A. Burke, 1998, Nature Biotechnology.

Rabbit muscle creatine phosphokinase. CDNA cloning, primary structure and detection of human homologues.

W. Herlihy, K. Biemann, H. Pang, 1984, The Journal of biological chemistry.

A formalin-inactivated whole SIV vaccine confers protection in macaques.

R. Montelaro, A. Allison, M. Murphey-Corb, 1989, Science.

The complete nucleotide sequence for rabbit muscle aldolase A messenger RNA.

E. Penhoet, M. Urdea, S. Putney, 1984, The Journal of biological chemistry.

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

W. Schleif, E. Emini, J. Nunberg, 1992, Nature.

A new troponin T and cDNA clones for 13 different muscle proteins, found by shotgun sequencing

W. Herlihy, P. Schimmel, S. Putney, 1983, Nature.

A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160.

J. Berzofsky, B. Moss, R. Germain, 1989, Science.

Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC types.

J. Berzofsky, M. Clerici, G. Shearer, 1991, The Journal of clinical investigation.

An aminoacyl tRNA synthetase binds to a specific DNA sequence and regulates its gene transcription

P. Schimmel, S. Putney, 1981, Nature.

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.

A J Langlois, L. Eckler, D. Bolognesi, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope

S. Matsushita, M. Robert-Guroff, A. Koito, 1988, Journal of virology.

Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type IIIB and in human immunodeficiency virus-infected men.

L. Arthur, R. Gallo, F. Wong-Staal, 1987, Proceedings of the National Academy of Sciences of the United States of America.

An HTLV-III peptide produced by recombinant DNA is immunoreactive with sera from patients with AIDS

J. Ghrayeb, P. Chanda, R. Gallo, 1985, Nature.

Comparisons of creatine kinase primary structures

I. Kuntz, F. Cohen, P. Babbitt, 1986 .

Improving protein therapeutics: the evolution of the modern pharmacopoeia

S. Putney, P. Burke, 2001 .

A month–long effect from a single injection of microencapsulated human growth hormone

A. Shahzamani, J. Cleland, Jeffrey L. Cleland, 1996, Nature Medicine.

Primary structure of a large aminoacyl-tRNA synthetase.

W. Herlihy, K. Biemann, P. Schimmel, 1981, Science.

Cloning, partial sequencing, and in vitro transcription of the gene for alanine tRNA synthetase.

P. Schimmel, S. Putney, D. Meléndez, 1981, The Journal of biological chemistry.

RNA and DNA sequence recognition and structure-function of aminoacyl tRNA synthetases

R. Starzyk, P. Schimmel, S. Putney, 1982 .

GENES FOR TWO E. COLI AMINOACYL tRNA SYNTHETASES

P. Schimmel, T. Keng, S. Putney, 1982 .

Purification and properties of alanine tRNA synthetase from Escherichia coli A tetramer of identical subunits.

R. Sauer, P. Schimmel, S. Putney, 1981, The Journal of biological chemistry.

How antibodies block HIV infection: paths to an AIDS vaccine.

S. Putney, S Putney, 1992, Trends in biochemical sciences.

In vivo characterization of sustained-release formulations of human growth hormone.

A. Shahzamani, A. Jones, J. Cleland, 1997, The Journal of pharmacology and experimental therapeutics.

Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain.

J. Robinson, A. Profy, K. Weinhold, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Antigenic variation in HIV.

J. McKeating, S. Putney, 1990, AIDS.

A DNA fragment with an alpha-phosphorothioate nucleotide at one end is asymmetrically blocked from digestion by exonuclease III and can be replicated in vivo.

S. Benkovic, P. Schimmel, S J Benkovic, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Enhanced anti-tumor effects with microencapsulated c-myc antisense oligonucleotide.

C. Leonetti, T. Geiser, G. Zon, 1999, Antisense & nucleic acid drug development.

Cerebral cell adhesion molecule: a novel leukocyte adhesion determinant on blood-brain barrier capillary endothelium.

R. Starzyk, E. Tuomanen, S. Putney, 2000, The Journal of infectious diseases.

Synthetic peptide derived from the Bordetella pertussis bacterium reduces infarct volume after transient middle cerebral artery occlusion in the rat

M. Chopp, R. Starzyk, Z. Zhang, 1996, Neurology.

Epitopes recognized by the neutralizing antibodies of an HIV-1-infected individual.

L. Eckler, A. Profy, P. Nara, 1990, Journal of immunology.

Peptides containing multideterminant clusters of human immunodeficiency virus envelope induce murine and human T-cell responses in diverse histocompatibility types.

J. Berzofsky, M. Clerici, G. Shearer, 1991, Transactions of the Association of American Physicians.

Production and characterization of fusion proteins containing transferrin and nerve growth factor.

R. Starzyk, T. Lee, S. Putney, 1998, Journal of drug targeting.

Priming with T helper cell epitope peptides enhances the antibody response to the envelope glycoprotein of HIV-1 in primates.

K. Cease, R. Desrosiers, M. Zweig, 1991, Journal of immunology.

Mass spectra of partial protein hydrolysates as a multiple phase check for long polypeptides deduced from DNA sequences: NH2-terminal segment of alanine tRNA synthetase.

W. Herlihy, K. Biemann, P. Schimmel, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Inhibition of leukocyte-endothelial cell interactions and inflammation by peptides from a bacterial adhesin which mimic coagulation factor X.

R. Starzyk, B. Spellerberg, A. Young, 1995, The Journal of clinical investigation.

Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein

S. Putney, Ronald N. Germain, J. A. Berzofsky, 1989, The Journal of experimental medicine.

A formalin inactivated whole SIV vaccine and a glycoprotein-enriched subunit vaccine confers protection against experimental challenge with pathogenic live SIV in rhesus monkeys.

R. Montelaro, S. Putney, M. West, 1990, Developments in biological standardization.

Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1

A. Profy, S. Putney, K. Javaherian, 1990, Science.

Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells.

M. Robert-Guroff, H. Lyerly, R. Gallo, 1987, Proceedings of the National Academy of Sciences of the United States of America.